When was TransMedics founded?

TransMedics was founded in 1998 and raised its 1st funding round 2 years after it was founded.

Where is TransMedics located?

TransMedics is headquartered in Andover, United States. It is registered at Andover, Massachusetts.

How many employees does TransMedics have?

As of Apr 30, 2026, the latest employee count at TransMedics is 673.

Is TransMedics a funded company?

TransMedics is a funded company, having raised a total of $266M across 16 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 2000.

When was the latest funding round of TransMedics?

TransMedics' latest funding was a $***** Conventional Debt round on Sep 15, 2022, with participation from 1 investor. Its primary sector is Transplant Medicine. In United States, the Transplant Medicine sector has seen $49.9M in funding in 2026 to date.

What is the annual revenue of TransMedics?

Annual revenue of TransMedics is $605M as on Dec 31, 2025.

Where does TransMedics rank among its competitors?

TransMedics ranks 2nd amongst 29 active competitors, of which 9 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Untillabs, which secured $58M in Sep, 2025.

Who are the top competitors of TransMedics?

TransMedics' top competitors include OrganOx, Paragonix Technologies and Bridge to Life. Among them, Untillabs secured the most recent funding round in September, 2025.

TransMedics - 2026 Company Profile, Funding, Competitors & Financials

TransMedics is a public company based in Andover (United States), founded in 1998. It operates as a Developer of organ transplantation technology. TransMedics has raised $266M in funding from investors like Kleiner Perkins, Foundation Capital and Hercules Capital. The company has 29 active competitors, including 9 funded and 6 that have exited. Its top competitors include companies like OrganOx, Paragonix Technologies and Bridge to Life.

Company Details

Developer of organ transplantation technology. The company has developed the Organ Care System (OCS), an organ transplant technology that maintains organs in a living functioning state outside the body to provide. The system consists of a portable platform with a wireless monitor, a perfusion module specific to the organ, and a solution set. They have made OCS for the heart, lungs, and liver.

Website: www.transmedics.com/
Social
Registered Address: Andover, Massachusetts

Key Metrics

Founded Year

1998

Location

Andover, United States

Stage

Public

Total Funding

$266M in 16 rounds

Latest Funding Round

Conventional Debt, Sep 15, 2022, $*****

Investors

Kleiner Perkins & 20 more

Ranked

2^nd among 29 active competitors

Annual Revenue

$605M as on Dec 31, 2025

Employee Count

673 as on Apr 30, 2026

Investment & Acquisitions

Padaviation & 2 more

Similar Companies

OrganOx & 35 more

Exit Details

Public

View TransMedics' full profile

TransMedics is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Uni - Trans Georgia s.r.o. CIN: 07452004 , Czech Republic, Active	Sep 12, 2018	-	-
TRANSMEDICS GROUP, INC. CIN: 1756262 , United States, Active		$605M (As on Dec 31, 2025)	584 (As on Dec 31, 2023)	-
Transmedic Czech s.r.o. CIN: 25689142 , Czech Republic, Active	Aug 19, 1998	-	-
Transmedics, Inc. CIN: 43432735 , United States, Active	Dec 26, 999	-	710 (As on Dec 31, 2024)	-

TransMedics got listed on May 02, 2019.

Click here to take a look at TransMedics's IPO in detail

TransMedics has raised a total funding of $266M over 16 rounds. Its first funding round was on Sep 2000. Its latest funding round was a Conventional Debt round on Sep 15, 2022 for $*****. 1 investor participated in its latest round. TransMedics has 21 institutional investors.

Here is the list of recent funding rounds of TransMedics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 15, 2022	9969448	Conventional Debt	8892438	4741485	6918691	5277697
Jul 11, 2016	6724937	Series F	1490612	8008154	9382581	Abrams Capital & 4 more
Sep 11, 2015	6496154	Series F	4255476	7536278	6849103	6775167

Access funding benchmarks and valuations. Sign up today!

View details of TransMedics's funding rounds and investors

TransMedics' employee count trend

TransMedics has 673 employees as of Apr 26. Here is TransMedics's employee count trend over the years:

Uncover TransMedics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TransMedics include OrganOx, Paragonix Technologies and Bridge to Life. Here is the list of Top 10 competitors of TransMedics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OrganOx 2008, Oxford (United Kingdom), Acquired	Provider of a storage and transport system for harvested organs	$45.4M	Health Quest Capital, BGF & 61 others	72/100
2nd	TransMedics 1998, Andover (United States), Public	Developer of organ transplantation technology	$266M	Hercules Capital, Orbimed & 19 others	67/100
3rd	Paragonix Technologies 2010, Boston (United States), Acquired	Organ preservation technology improving transplant outcomes with digital tracking and clinical support	$25.1M	Signet Healthcare Partners, Massachusetts Life Sciences Center ... & 1 others	57/100
4th	Bridge to Life 2012, Columbia (United States), Series A	Provider of cold storage solutions for the preservation of organ transplants	$57M	Perceptive Advisors, SCRA	56/100
5th	Vascular Perfusion 2016, San Antonio (United States), Series D	Developer of a device for organ preservation	$152M	Capital Factory, Military Health	53/100
6th	XVIVO 1998, Gothenburg (Sweden), Public	Provider of organ preservation technologies and services. It offers machine perfusion technologies for kidneys, livers, and lungs, and a solution for cold static storage of lungs. The company also provides organ recovery and perfusion services. These technologies aim to increase organ utilization, extend preservation time, enable organ assessment, and improve transplant outcomes. A platform for sharing knowledge and experiences related to organ perfusion is also offered.	-	Europa	45/100
7th	Untillabs 2021, San Francisco (United States), Series A	Developer of reversible cryopreservation systems for human organs and tissues	$100M	Founders Fund, fieldvc.com & 1 others	45/100
8th	ADVITOS 2005, Munich (Germany), Series B	Provider of multi-organ support systems	$23.8M	Credit Mutuel Equity, Kfw & 13 others	43/100
9th	Organ Recovery Systems 1998, Itasca (United States), Funding Raised	Organ preservation products and services improving transplant outcomes for patients	-	HHS	38/100
10th	Transplant Biomedicals 2014, Barcelona (Spain), Series A	Organ transport devices	$4.24M	Caixa Capital Risc, Kereon Partners	37/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on TransMedics's competitors? Click here to see the top ones

TransMedics has made 1 investment in Padaviation and acquired Summit-Aviation and Summit Aviation.

Here is the list of these investments and acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Apr 29, 2026	Investments	Padaviation	2006	Germany
Aug 16, 2023	Acquisition	Summit-Aviation	1960	Middletown (United States)
Aug 01, 2023	Acquisition	Summit Aviation	2000	Belgrade (United States)